genOway, a French Biotechnology Company Specializing in Highly Predictive Preclinical Research Models, Establishes its Japanese Subsidiary
Founded in 1999 in Lyon, France, genOway is a biotechnology company specializing in immuno-oncology and immunotherapy. The company provides customized preclinical research models and scientific consulting services to pharmaceutical companies and research institutions to improve drug discovery success rates.
With strong expertise in genetically modified mouse models, genOway has built a solid track record in the U.S. and European markets. Recognizing Japan as the world’s third-largest preclinical research market, the company established genOway Japan K.K. in Chuo-ku, Tokyo, in February 2026.
Through its Japanese subsidiary, genOway aims to strengthen collaboration with local customers and expand its highly valued research solutions in Japan.
Global Gateway Advisors, we are the preferred partner in assisting companies from all over Asia in their expansion into Japan market.
